AVEANNA HEALTHCARE HOLDINGS

Insider selling spree at Aveanna Healthcare: J.H. Whitney liquidates 10M+ shares at $11.50, below market. Explore the impact on dilution, control shifts, and investor strategy.

CEO Jeff sells 90k shares of Aveanna before a $15 M secondary offering, sparking insider confidence yet hinting at future dilution risks.

Insider sell‑offs at Aveanna Healthcare spike—over 18M shares off the market—raise short‑term price pressure, yet a 5.8 P/E and pediatric expansion may offer buying value at $6.63.